a double-blind cross-over trial was carried out in 50 patients with definite rheumatoid arthritis , in order to compare the effects of 300 mg/day of ketoprofen with those of 600 mg/day of phenylbutazone , e.g . the maximal clinically used doses of each drug .
C0003873
rheumatoid arthritis
C0022635
ketoprofen